Antibodies inhibiting the interaction of LRP6 with Wnt1 or Wnt3a decrease breast tumor growth in Wnt1- and Wnt3a-driven xenografts, respectively [40, 41]. The gene discussed is WNT1; the disease is breast neoplasm.